It has been an eventful start to the year for BiBBInstruments. While the standout moment was the FDA market clearance for EndoDrill GI, the Swedish medtech posted a number other key milestones that are sure to work as a springboard for the rest of the year. BioStock got in touch with BiBB's CEO Fredrik Lindblad to learn more.

Read the interview with Fredrik Lindblad at biostock.se:

https://www.biostock.se/en/2023/08/bibb-coming-off-strong-first-half-of-2023/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

https://news.cision.com/bibbinstruments-ab/r/biostock--bibb-coming-off-strong-first-half-of-2023,c3825864

(c) 2023 Cision. All rights reserved., source Press Releases - English